Review



cd24 antibody, anti-mouse  (Miltenyi Biotec)


Bioz Verified Symbol Miltenyi Biotec is a verified supplier
Bioz Manufacturer Symbol Miltenyi Biotec manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Miltenyi Biotec cd24 antibody, anti-mouse
    Cd24 Antibody, Anti Mouse, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 113 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd24 antibody, anti-mouse/product/Miltenyi Biotec
    Average 94 stars, based on 113 article reviews
    cd24 antibody, anti-mouse - by Bioz Stars, 2026-06
    94/100 stars

    Images



    Similar Products

    94
    Miltenyi Biotec cd24 antibody, anti-mouse
    Cd24 Antibody, Anti Mouse, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd24 antibody, anti-mouse/product/Miltenyi Biotec
    Average 94 stars, based on 1 article reviews
    cd24 antibody, anti-mouse - by Bioz Stars, 2026-06
    94/100 stars
      Buy from Supplier

    93
    Miltenyi Biotec bw4
    Bw4, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bw4/product/Miltenyi Biotec
    Average 93 stars, based on 1 article reviews
    bw4 - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    96
    Proteintech cd24
    Cd24, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd24/product/Proteintech
    Average 96 stars, based on 1 article reviews
    cd24 - by Bioz Stars, 2026-06
    96/100 stars
      Buy from Supplier

    93
    Miltenyi Biotec reafinity antibody
    Reafinity Antibody, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/reafinity antibody/product/Miltenyi Biotec
    Average 93 stars, based on 1 article reviews
    reafinity antibody - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    95
    Proteintech cd24 antibody
    Cd24 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd24 antibody/product/Proteintech
    Average 95 stars, based on 1 article reviews
    cd24 antibody - by Bioz Stars, 2026-06
    95/100 stars
      Buy from Supplier

    93
    Miltenyi Biotec cd24
    A) Chromosomal tracks depicting RUNX1 binding, chromatin contacts, ATAC and H3K27ac signals at chr15-101Mb region encompassing the ALDH1A3 locus that is upregulated upon the loss of RUNX1. B) Flow cytometry histograms of ALDH activity measured by an ALDEred assay at different timepoints following RUNX1 ablation. C) Quantification of ALDH high cells above DEAB-ALDH inhibitory controls indicate the percentage of cells that are ALDH bright in the DMSO baseline versus dTAGV1 treatment. D) Flow cytometry histograms of <t>CD24</t> staining at different timepoints following RUNX1 ablation. E) Quantification of CD24+ cells above isotype controls indicates the percentage of CD24 high non-BCSCs in DMSO versus dTAGV1 treatment. F) MCF10A-R1F cells initially treated for 24hrs with DMSO or dTAGV1 were then subsequently placed in an anchorage-independent condition demonstrating an increased number of viable cells upon RUNX1 ablation. G) Relative MTS absorbance (450nm) as a measure of cell metabolism/ viability. Values are expressed as a percentage of vehicle control absorbance at multiple 4-hydroxycyclophosphamide (4-HC) dosages at 48hrs.
    Cd24, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd24/product/Miltenyi Biotec
    Average 93 stars, based on 1 article reviews
    cd24 - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    95
    Thermo Fisher gene exp cd24 hs02379687 s1
    A) Chromosomal tracks depicting RUNX1 binding, chromatin contacts, ATAC and H3K27ac signals at chr15-101Mb region encompassing the ALDH1A3 locus that is upregulated upon the loss of RUNX1. B) Flow cytometry histograms of ALDH activity measured by an ALDEred assay at different timepoints following RUNX1 ablation. C) Quantification of ALDH high cells above DEAB-ALDH inhibitory controls indicate the percentage of cells that are ALDH bright in the DMSO baseline versus dTAGV1 treatment. D) Flow cytometry histograms of <t>CD24</t> staining at different timepoints following RUNX1 ablation. E) Quantification of CD24+ cells above isotype controls indicates the percentage of CD24 high non-BCSCs in DMSO versus dTAGV1 treatment. F) MCF10A-R1F cells initially treated for 24hrs with DMSO or dTAGV1 were then subsequently placed in an anchorage-independent condition demonstrating an increased number of viable cells upon RUNX1 ablation. G) Relative MTS absorbance (450nm) as a measure of cell metabolism/ viability. Values are expressed as a percentage of vehicle control absorbance at multiple 4-hydroxycyclophosphamide (4-HC) dosages at 48hrs.
    Gene Exp Cd24 Hs02379687 S1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gene exp cd24 hs02379687 s1/product/Thermo Fisher
    Average 95 stars, based on 1 article reviews
    gene exp cd24 hs02379687 s1 - by Bioz Stars, 2026-06
    95/100 stars
      Buy from Supplier

    94
    Miltenyi Biotec pe anti mouse cd24
    A) Chromosomal tracks depicting RUNX1 binding, chromatin contacts, ATAC and H3K27ac signals at chr15-101Mb region encompassing the ALDH1A3 locus that is upregulated upon the loss of RUNX1. B) Flow cytometry histograms of ALDH activity measured by an ALDEred assay at different timepoints following RUNX1 ablation. C) Quantification of ALDH high cells above DEAB-ALDH inhibitory controls indicate the percentage of cells that are ALDH bright in the DMSO baseline versus dTAGV1 treatment. D) Flow cytometry histograms of <t>CD24</t> staining at different timepoints following RUNX1 ablation. E) Quantification of CD24+ cells above isotype controls indicates the percentage of CD24 high non-BCSCs in DMSO versus dTAGV1 treatment. F) MCF10A-R1F cells initially treated for 24hrs with DMSO or dTAGV1 were then subsequently placed in an anchorage-independent condition demonstrating an increased number of viable cells upon RUNX1 ablation. G) Relative MTS absorbance (450nm) as a measure of cell metabolism/ viability. Values are expressed as a percentage of vehicle control absorbance at multiple 4-hydroxycyclophosphamide (4-HC) dosages at 48hrs.
    Pe Anti Mouse Cd24, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pe anti mouse cd24/product/Miltenyi Biotec
    Average 94 stars, based on 1 article reviews
    pe anti mouse cd24 - by Bioz Stars, 2026-06
    94/100 stars
      Buy from Supplier

    94
    Proteintech antibodies against cd24
    Radiation enhances tumor cell “do not eat me” signal <t>CD24.</t> A, UMAP plots of pancreatic adenocarcinoma with 10 clusters, NCBI Sequence Read Archive: GSE281288 . <t>CD24</t> expression overlaid onto UMAP. B, Immunofluorescence images of CD24 (red) on control or irradiated H460 cells. Scale bars, 25 and 5 µm. C and D, Flow cytometry histograms and mean fluorescence intensity (MFI) of CD24 surface expression on control or irradiated H460 ( C ) and PANC-1 ( D ) cells ( n = 3). E, Tumor cell CD24 mean fluorescence intensity from control or irradiated KPC tumor models ( n = 6). F, Flow cytometry histograms and mean fluorescence intensity of CD24 surface expression on H460 cells 48 hours after 2–18 Gy of radiation ( n = 3). IR, 8 Gy irradiation. All data are presented as mean ± SEM and normalized to the control group. A two-tailed Student t test was performed for C–E . One-way ANOVA with a Tukey multiple comparisons test was performed for F . NS, not significant.
    Antibodies Against Cd24, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibodies against cd24/product/Proteintech
    Average 94 stars, based on 1 article reviews
    antibodies against cd24 - by Bioz Stars, 2026-06
    94/100 stars
      Buy from Supplier

    Image Search Results


    A) Chromosomal tracks depicting RUNX1 binding, chromatin contacts, ATAC and H3K27ac signals at chr15-101Mb region encompassing the ALDH1A3 locus that is upregulated upon the loss of RUNX1. B) Flow cytometry histograms of ALDH activity measured by an ALDEred assay at different timepoints following RUNX1 ablation. C) Quantification of ALDH high cells above DEAB-ALDH inhibitory controls indicate the percentage of cells that are ALDH bright in the DMSO baseline versus dTAGV1 treatment. D) Flow cytometry histograms of CD24 staining at different timepoints following RUNX1 ablation. E) Quantification of CD24+ cells above isotype controls indicates the percentage of CD24 high non-BCSCs in DMSO versus dTAGV1 treatment. F) MCF10A-R1F cells initially treated for 24hrs with DMSO or dTAGV1 were then subsequently placed in an anchorage-independent condition demonstrating an increased number of viable cells upon RUNX1 ablation. G) Relative MTS absorbance (450nm) as a measure of cell metabolism/ viability. Values are expressed as a percentage of vehicle control absorbance at multiple 4-hydroxycyclophosphamide (4-HC) dosages at 48hrs.

    Journal: bioRxiv

    Article Title: Acute degron-mediated RUNX1 loss reprograms enhancer activity to epigenetically drive epithelial destabilization and initiate cancer hallmarks

    doi: 10.64898/2026.03.26.711344

    Figure Lengend Snippet: A) Chromosomal tracks depicting RUNX1 binding, chromatin contacts, ATAC and H3K27ac signals at chr15-101Mb region encompassing the ALDH1A3 locus that is upregulated upon the loss of RUNX1. B) Flow cytometry histograms of ALDH activity measured by an ALDEred assay at different timepoints following RUNX1 ablation. C) Quantification of ALDH high cells above DEAB-ALDH inhibitory controls indicate the percentage of cells that are ALDH bright in the DMSO baseline versus dTAGV1 treatment. D) Flow cytometry histograms of CD24 staining at different timepoints following RUNX1 ablation. E) Quantification of CD24+ cells above isotype controls indicates the percentage of CD24 high non-BCSCs in DMSO versus dTAGV1 treatment. F) MCF10A-R1F cells initially treated for 24hrs with DMSO or dTAGV1 were then subsequently placed in an anchorage-independent condition demonstrating an increased number of viable cells upon RUNX1 ablation. G) Relative MTS absorbance (450nm) as a measure of cell metabolism/ viability. Values are expressed as a percentage of vehicle control absorbance at multiple 4-hydroxycyclophosphamide (4-HC) dosages at 48hrs.

    Article Snippet: Cells were stained with CD24 (Miltenyi Biotec, 130-108-352) or isotype (Miltenyi Biotec, 130-124-062) antibodies at the manufacturer’s suggested concentration for 20 minutes at 4°C, washed and acquired using a MACSquant YVB.

    Techniques: Binding Assay, Flow Cytometry, Activity Assay, Staining, Control

    Radiation enhances tumor cell “do not eat me” signal CD24. A, UMAP plots of pancreatic adenocarcinoma with 10 clusters, NCBI Sequence Read Archive: GSE281288 . CD24 expression overlaid onto UMAP. B, Immunofluorescence images of CD24 (red) on control or irradiated H460 cells. Scale bars, 25 and 5 µm. C and D, Flow cytometry histograms and mean fluorescence intensity (MFI) of CD24 surface expression on control or irradiated H460 ( C ) and PANC-1 ( D ) cells ( n = 3). E, Tumor cell CD24 mean fluorescence intensity from control or irradiated KPC tumor models ( n = 6). F, Flow cytometry histograms and mean fluorescence intensity of CD24 surface expression on H460 cells 48 hours after 2–18 Gy of radiation ( n = 3). IR, 8 Gy irradiation. All data are presented as mean ± SEM and normalized to the control group. A two-tailed Student t test was performed for C–E . One-way ANOVA with a Tukey multiple comparisons test was performed for F . NS, not significant.

    Journal: Cancer Research

    Article Title: Radiation-Enhanced CD24 Membrane Trafficking via GPI Anchoring Mediates Antitumor Immune Evasion

    doi: 10.1158/0008-5472.CAN-25-2616

    Figure Lengend Snippet: Radiation enhances tumor cell “do not eat me” signal CD24. A, UMAP plots of pancreatic adenocarcinoma with 10 clusters, NCBI Sequence Read Archive: GSE281288 . CD24 expression overlaid onto UMAP. B, Immunofluorescence images of CD24 (red) on control or irradiated H460 cells. Scale bars, 25 and 5 µm. C and D, Flow cytometry histograms and mean fluorescence intensity (MFI) of CD24 surface expression on control or irradiated H460 ( C ) and PANC-1 ( D ) cells ( n = 3). E, Tumor cell CD24 mean fluorescence intensity from control or irradiated KPC tumor models ( n = 6). F, Flow cytometry histograms and mean fluorescence intensity of CD24 surface expression on H460 cells 48 hours after 2–18 Gy of radiation ( n = 3). IR, 8 Gy irradiation. All data are presented as mean ± SEM and normalized to the control group. A two-tailed Student t test was performed for C–E . One-way ANOVA with a Tukey multiple comparisons test was performed for F . NS, not significant.

    Article Snippet: Membranes were blocked with 5% nonfat milk for 1 hour at room temperature, incubated with antibodies against CD24 (Abways, cat. #DY1303, RRID: AB_3073211), GPAA1 (Proteintech, cat. #10104-1-AP, RRID: AB_2263708), and ANAPC5 (Proteintech, cat. #67348-1-Ig, RRID: AB_2882606) primary antibodies at 4°C overnight, washed with TBST, and then incubated with horseradish peroxidase–conjugated secondary antibodies for 1 hour at room temperature.

    Techniques: Sequencing, Expressing, Immunofluorescence, Control, Irradiation, Flow Cytometry, Fluorescence, Two Tailed Test

    CD24 inhibition combined with radiation promotes macrophages phagocytosis and activation. A and B, Flow cytometry histograms of CD24 surface expression on H460 ( A ) and PANC-1 ( B ) cells transfected with CD24 -targeting siRNA (si CD24 ), negative-control siRNA (siNC), or isotype control. C and D, Flow cytometry histograms and quantitation of H460 ( C ) and PANC-1 ( D ) cell phagocytosis by THP-1 macrophages, with the indicated treatments ( n = 3). E, Immunofluorescence images and quantitation of H460 cell phagocytosis by THP-1 macrophages (red), with the indicated treatments (green). Arrows, phagocytic events ( n = 6). Scale bars, 50 μm. F, qRT-PCR analysis of Siglec- 10 in THP-1 macrophages transfected with si Siglec- 10 or siNC ( n = 3). G, Flow cytometry histograms and quantitation of irradiated H460 cell phagocytosis by THP-1 macrophages, with the indicated treatments ( n = 3). H – J, Flow cytometry histograms and mean fluorescence intensity (MFI) of CD80 ( H ), CD86 ( I ), and PD-L1 ( J ) on BMDMs cocultured with tumor cells, with the indicated treatments ( n = 3). IR, 8 Gy irradiation. All data are presented as mean ± SEM. One-way ANOVA with a Tukey multiple comparisons test was performed for C–E and G–J . A two-tailed Student t test was performed for F . NS, not significant.

    Journal: Cancer Research

    Article Title: Radiation-Enhanced CD24 Membrane Trafficking via GPI Anchoring Mediates Antitumor Immune Evasion

    doi: 10.1158/0008-5472.CAN-25-2616

    Figure Lengend Snippet: CD24 inhibition combined with radiation promotes macrophages phagocytosis and activation. A and B, Flow cytometry histograms of CD24 surface expression on H460 ( A ) and PANC-1 ( B ) cells transfected with CD24 -targeting siRNA (si CD24 ), negative-control siRNA (siNC), or isotype control. C and D, Flow cytometry histograms and quantitation of H460 ( C ) and PANC-1 ( D ) cell phagocytosis by THP-1 macrophages, with the indicated treatments ( n = 3). E, Immunofluorescence images and quantitation of H460 cell phagocytosis by THP-1 macrophages (red), with the indicated treatments (green). Arrows, phagocytic events ( n = 6). Scale bars, 50 μm. F, qRT-PCR analysis of Siglec- 10 in THP-1 macrophages transfected with si Siglec- 10 or siNC ( n = 3). G, Flow cytometry histograms and quantitation of irradiated H460 cell phagocytosis by THP-1 macrophages, with the indicated treatments ( n = 3). H – J, Flow cytometry histograms and mean fluorescence intensity (MFI) of CD80 ( H ), CD86 ( I ), and PD-L1 ( J ) on BMDMs cocultured with tumor cells, with the indicated treatments ( n = 3). IR, 8 Gy irradiation. All data are presented as mean ± SEM. One-way ANOVA with a Tukey multiple comparisons test was performed for C–E and G–J . A two-tailed Student t test was performed for F . NS, not significant.

    Article Snippet: Membranes were blocked with 5% nonfat milk for 1 hour at room temperature, incubated with antibodies against CD24 (Abways, cat. #DY1303, RRID: AB_3073211), GPAA1 (Proteintech, cat. #10104-1-AP, RRID: AB_2263708), and ANAPC5 (Proteintech, cat. #67348-1-Ig, RRID: AB_2882606) primary antibodies at 4°C overnight, washed with TBST, and then incubated with horseradish peroxidase–conjugated secondary antibodies for 1 hour at room temperature.

    Techniques: Inhibition, Activation Assay, Flow Cytometry, Expressing, Transfection, Negative Control, Control, Quantitation Assay, Immunofluorescence, Quantitative RT-PCR, Irradiation, Fluorescence, Two Tailed Test

    Radiation enhances CD24 membrane trafficking via GPI anchoring. A and B, Western blot analysis of CD24 in control or irradiated H460 ( A ) and PANC-1 ( B ) whole-cell lysate. C, Schematic representation of GPI anchoring. D, Western blot analysis of CD24 in control or irradiated H460 cell membrane and cytosolic lysate. E, Proteomic analysis heatmap of differential proteins in control or irradiated H1299. F and G, Western blot analysis of GPAA1 in control or irradiated H460 ( F ) and PANC-1 ( G ) whole-cell lysate. H, Western blot analysis of GPAA1 and CD24 in H460 cells transfected with si GPAA1 or siNC. I, Flow cytometry histograms of CD24 surface expression on H460 cells, with the indicated treatment or isotype control ( n = 3). MFI, mean fluorescence intensity. J, Flow cytometry histograms and quantitation of H460 cell phagocytosis by THP-1 macrophages, with the indicated treatments ( n = 3). IR, 8 Gy irradiation. All data are presented as mean ± SEM and compared using one-way ANOVA with a Tukey multiple comparisons test. NS, not significant.

    Journal: Cancer Research

    Article Title: Radiation-Enhanced CD24 Membrane Trafficking via GPI Anchoring Mediates Antitumor Immune Evasion

    doi: 10.1158/0008-5472.CAN-25-2616

    Figure Lengend Snippet: Radiation enhances CD24 membrane trafficking via GPI anchoring. A and B, Western blot analysis of CD24 in control or irradiated H460 ( A ) and PANC-1 ( B ) whole-cell lysate. C, Schematic representation of GPI anchoring. D, Western blot analysis of CD24 in control or irradiated H460 cell membrane and cytosolic lysate. E, Proteomic analysis heatmap of differential proteins in control or irradiated H1299. F and G, Western blot analysis of GPAA1 in control or irradiated H460 ( F ) and PANC-1 ( G ) whole-cell lysate. H, Western blot analysis of GPAA1 and CD24 in H460 cells transfected with si GPAA1 or siNC. I, Flow cytometry histograms of CD24 surface expression on H460 cells, with the indicated treatment or isotype control ( n = 3). MFI, mean fluorescence intensity. J, Flow cytometry histograms and quantitation of H460 cell phagocytosis by THP-1 macrophages, with the indicated treatments ( n = 3). IR, 8 Gy irradiation. All data are presented as mean ± SEM and compared using one-way ANOVA with a Tukey multiple comparisons test. NS, not significant.

    Article Snippet: Membranes were blocked with 5% nonfat milk for 1 hour at room temperature, incubated with antibodies against CD24 (Abways, cat. #DY1303, RRID: AB_3073211), GPAA1 (Proteintech, cat. #10104-1-AP, RRID: AB_2263708), and ANAPC5 (Proteintech, cat. #67348-1-Ig, RRID: AB_2882606) primary antibodies at 4°C overnight, washed with TBST, and then incubated with horseradish peroxidase–conjugated secondary antibodies for 1 hour at room temperature.

    Techniques: Membrane, Western Blot, Control, Irradiation, Transfection, Flow Cytometry, Expressing, Fluorescence, Quantitation Assay

    Radiation disrupts APC/C-mediated ubiquitination of GPAA1 at K111. A, Schematic illustration of IP-MS approach. B, GO enrichment analysis (Biological Process) of GPAA1-interacting proteins predicted in IP-MS. C and D, Western blot analysis of cycloheximide (CHX) chase assay in H460 cells treated with MG132 ( C ) or radiation ( D ). E, Western blot analysis followed by IP evaluated the ubiquitination of GPAA1 in indicated treatment groups. F, Western blot analysis of GPAA1 in H460 cells treated with apcin. G, Flow cytometry histograms of CD24 surface expression on H460 cells treated with apcin or isotype control ( n = 3). MFI, mean fluorescence intensity. H, Schematic illustration of screening GPAA1-binding APC/C subunits. I, IP analysis of the GPAA1–ANAPC5 interaction. J, Western blot analysis followed by IP evaluated GPAA1 ubiquitination in H460 cells transfected with si ANAPC5 or siNC. K, Western blot analysis of ANAPC5 and GPAA1 in H460 cells transfected with si ANAPC5 or siNC. L, Flow cytometry histograms of CD24 surface expression on H460 cells transfected with si ANAPC5 , siNC, or isotype control ( n = 3). M, Western blot analysis followed by IP evaluated GPAA1 ubiquitination in 293T cells transfected with different mutants. IR, 8 Gy irradiation. All data are presented as mean ± SEM. One-way ANOVA with a Tukey multiple comparisons test was performed for G . A two-tailed Student t test was performed for L . WT, wild type.

    Journal: Cancer Research

    Article Title: Radiation-Enhanced CD24 Membrane Trafficking via GPI Anchoring Mediates Antitumor Immune Evasion

    doi: 10.1158/0008-5472.CAN-25-2616

    Figure Lengend Snippet: Radiation disrupts APC/C-mediated ubiquitination of GPAA1 at K111. A, Schematic illustration of IP-MS approach. B, GO enrichment analysis (Biological Process) of GPAA1-interacting proteins predicted in IP-MS. C and D, Western blot analysis of cycloheximide (CHX) chase assay in H460 cells treated with MG132 ( C ) or radiation ( D ). E, Western blot analysis followed by IP evaluated the ubiquitination of GPAA1 in indicated treatment groups. F, Western blot analysis of GPAA1 in H460 cells treated with apcin. G, Flow cytometry histograms of CD24 surface expression on H460 cells treated with apcin or isotype control ( n = 3). MFI, mean fluorescence intensity. H, Schematic illustration of screening GPAA1-binding APC/C subunits. I, IP analysis of the GPAA1–ANAPC5 interaction. J, Western blot analysis followed by IP evaluated GPAA1 ubiquitination in H460 cells transfected with si ANAPC5 or siNC. K, Western blot analysis of ANAPC5 and GPAA1 in H460 cells transfected with si ANAPC5 or siNC. L, Flow cytometry histograms of CD24 surface expression on H460 cells transfected with si ANAPC5 , siNC, or isotype control ( n = 3). M, Western blot analysis followed by IP evaluated GPAA1 ubiquitination in 293T cells transfected with different mutants. IR, 8 Gy irradiation. All data are presented as mean ± SEM. One-way ANOVA with a Tukey multiple comparisons test was performed for G . A two-tailed Student t test was performed for L . WT, wild type.

    Article Snippet: Membranes were blocked with 5% nonfat milk for 1 hour at room temperature, incubated with antibodies against CD24 (Abways, cat. #DY1303, RRID: AB_3073211), GPAA1 (Proteintech, cat. #10104-1-AP, RRID: AB_2263708), and ANAPC5 (Proteintech, cat. #67348-1-Ig, RRID: AB_2882606) primary antibodies at 4°C overnight, washed with TBST, and then incubated with horseradish peroxidase–conjugated secondary antibodies for 1 hour at room temperature.

    Techniques: Ubiquitin Proteomics, Protein-Protein interactions, Western Blot, Flow Cytometry, Expressing, Control, Fluorescence, Binding Assay, Transfection, Irradiation, Two Tailed Test

    Targeting CD24 sensitizes tumor to radiotherapy and elicits abscopal effect in vivo . A, Schematic illustration of radiation treatment plan in animal models. B and C, Tumor growth curves ( B ) and Kaplan–Meier survival plot ( C ) of Hepa1-6 subcutaneous tumor models, with the indicated treatment ( n = 8). D and E, Tumor growth curves ( D ) and tumor weight ( E ) of KPC subcutaneous tumor models, with the indicated treatment ( n = 6). F and G, Tumor growth curves ( F ) and Kaplan–Meier survival plot ( G ) of KPC subcutaneous tumor models, with the indicated treatment ( n = 8). H, Schematic illustration of abscopal effect evaluation in animal models. I–K, Tumor growth curves of in situ ( I ) and abscopal tumors ( J ) and Kaplan–Meier survival plot ( K ) of KPC subcutaneous tumor models depicted in H ( n = 6). L, Schematic illustration of antibody treatment plan in animal models. M and N, Tumor growth curves ( M ) and Kaplan–Meier survival plot ( N ) of KPC subcutaneous tumor models depicted in L ( n = 7). IR, 8 Gy × 3 irradiation. All data are presented as mean ± SEM. Two-way ANOVA with a Tukey multiple comparisons test was performed for B , D , F , I , J , and M . One-way ANOVA with a Tukey multiple comparisons test was performed for E . A log-rank test was performed for C , G , K , and N . NS, not significant. A, H, and L, Created in BioRender. Kong, L. (2026) https://BioRender.com/rwdzfwn .

    Journal: Cancer Research

    Article Title: Radiation-Enhanced CD24 Membrane Trafficking via GPI Anchoring Mediates Antitumor Immune Evasion

    doi: 10.1158/0008-5472.CAN-25-2616

    Figure Lengend Snippet: Targeting CD24 sensitizes tumor to radiotherapy and elicits abscopal effect in vivo . A, Schematic illustration of radiation treatment plan in animal models. B and C, Tumor growth curves ( B ) and Kaplan–Meier survival plot ( C ) of Hepa1-6 subcutaneous tumor models, with the indicated treatment ( n = 8). D and E, Tumor growth curves ( D ) and tumor weight ( E ) of KPC subcutaneous tumor models, with the indicated treatment ( n = 6). F and G, Tumor growth curves ( F ) and Kaplan–Meier survival plot ( G ) of KPC subcutaneous tumor models, with the indicated treatment ( n = 8). H, Schematic illustration of abscopal effect evaluation in animal models. I–K, Tumor growth curves of in situ ( I ) and abscopal tumors ( J ) and Kaplan–Meier survival plot ( K ) of KPC subcutaneous tumor models depicted in H ( n = 6). L, Schematic illustration of antibody treatment plan in animal models. M and N, Tumor growth curves ( M ) and Kaplan–Meier survival plot ( N ) of KPC subcutaneous tumor models depicted in L ( n = 7). IR, 8 Gy × 3 irradiation. All data are presented as mean ± SEM. Two-way ANOVA with a Tukey multiple comparisons test was performed for B , D , F , I , J , and M . One-way ANOVA with a Tukey multiple comparisons test was performed for E . A log-rank test was performed for C , G , K , and N . NS, not significant. A, H, and L, Created in BioRender. Kong, L. (2026) https://BioRender.com/rwdzfwn .

    Article Snippet: Membranes were blocked with 5% nonfat milk for 1 hour at room temperature, incubated with antibodies against CD24 (Abways, cat. #DY1303, RRID: AB_3073211), GPAA1 (Proteintech, cat. #10104-1-AP, RRID: AB_2263708), and ANAPC5 (Proteintech, cat. #67348-1-Ig, RRID: AB_2882606) primary antibodies at 4°C overnight, washed with TBST, and then incubated with horseradish peroxidase–conjugated secondary antibodies for 1 hour at room temperature.

    Techniques: In Vivo, In Situ, Irradiation

    Low CD24 expression correlates with increased immune cell infiltration and prolonged survival across cancer types. A–E, Immunofluorescence images ( A ) and correlation analysis of CD24 average fluorescence intensity (AFI) with CD8 ( B ), CD68 ( C ), CD86 ( D ), and PD-L1 ( E ) expression from an independent high-grade serous ovarian cancer (HGSOC) array ( n = 44). Scale bars, 200 and 50 μm. F–H, Correlation analysis of CD24 expression levels with M1 macrophage ( F ), CD8 + T-cell ( G ), and CD8 + effector memory T-cell ( H ) infiltration levels in LUSC. Plotted by TIMER 2.0. TPM, transcripts per million. I, Overall survival period of patients with prostate adenocarcinoma (PRAD) receiving radiotherapy ( n = 77) stratified by CD24 expression levels based on the TCGA database. J and K, Overall survival of patients with hepatocellular carcinoma (LIHC; n = 370) stratified by CD24 ( J ) or GPAA1 ( K ) expression levels based on pan-cancer database of Kaplan–Meier plotter. L and M, Overall survival of patients with non–small cell lung cancer (NSCLC; n = 1,044) stratified by CD24 ( L ) or GPAA1 ( M ) expression levels based on SurveExpress lung meta-base. A Pearson correlation test was performed for B–E . R-squared, coefficient of determination. A log-rank test was performed for I–M . Hazard ratio (HR) and its 95% confidence interval were computed via a Cox proportional hazards regression model.

    Journal: Cancer Research

    Article Title: Radiation-Enhanced CD24 Membrane Trafficking via GPI Anchoring Mediates Antitumor Immune Evasion

    doi: 10.1158/0008-5472.CAN-25-2616

    Figure Lengend Snippet: Low CD24 expression correlates with increased immune cell infiltration and prolonged survival across cancer types. A–E, Immunofluorescence images ( A ) and correlation analysis of CD24 average fluorescence intensity (AFI) with CD8 ( B ), CD68 ( C ), CD86 ( D ), and PD-L1 ( E ) expression from an independent high-grade serous ovarian cancer (HGSOC) array ( n = 44). Scale bars, 200 and 50 μm. F–H, Correlation analysis of CD24 expression levels with M1 macrophage ( F ), CD8 + T-cell ( G ), and CD8 + effector memory T-cell ( H ) infiltration levels in LUSC. Plotted by TIMER 2.0. TPM, transcripts per million. I, Overall survival period of patients with prostate adenocarcinoma (PRAD) receiving radiotherapy ( n = 77) stratified by CD24 expression levels based on the TCGA database. J and K, Overall survival of patients with hepatocellular carcinoma (LIHC; n = 370) stratified by CD24 ( J ) or GPAA1 ( K ) expression levels based on pan-cancer database of Kaplan–Meier plotter. L and M, Overall survival of patients with non–small cell lung cancer (NSCLC; n = 1,044) stratified by CD24 ( L ) or GPAA1 ( M ) expression levels based on SurveExpress lung meta-base. A Pearson correlation test was performed for B–E . R-squared, coefficient of determination. A log-rank test was performed for I–M . Hazard ratio (HR) and its 95% confidence interval were computed via a Cox proportional hazards regression model.

    Article Snippet: Membranes were blocked with 5% nonfat milk for 1 hour at room temperature, incubated with antibodies against CD24 (Abways, cat. #DY1303, RRID: AB_3073211), GPAA1 (Proteintech, cat. #10104-1-AP, RRID: AB_2263708), and ANAPC5 (Proteintech, cat. #67348-1-Ig, RRID: AB_2882606) primary antibodies at 4°C overnight, washed with TBST, and then incubated with horseradish peroxidase–conjugated secondary antibodies for 1 hour at room temperature.

    Techniques: Expressing, Immunofluorescence, Fluorescence